Theradep
Clonmel, IE · Founded 2015 · 13 employees on LinkedIn · 1 known investors
TheraDep develops nanoscale plasma coating technology that bonds pharmaceuticals, biologics, and polymers onto surfaces such as metals, plastics, ceramics, and composites at room temperature. Its process targets manufacturers in the labware and medical device markets, offering custom coating solutions that integrate into existing production lines.
Also known as TheraDep · TheraDep Technologies, Inc.
Founders & leadership
Theradep was founded in 2015 by Liam O Neill, Liam O'Neill, Pat Burt, John O'Donoghue, and Liam.
Investors · 1
Company profile
researched Aug 2026TheraDep Technologies, Inc. is a surface engineering company that applies bioactive and pharmaceutical coatings to substrates using Cold Atmospheric Plasma (CAP). Its BioDep process uses low-temperature plasma to energize bioactive molecules so they form covalent bonds with a surface in a single dry step at room temperature, without heat or harsh chemistry. Because no polymer binders or chemical linkers are used, the resulting coating consists only of the active therapeutic or biologic material.
The company applies the technology across four stated application areas: single-step biologic coatings for microplates; cold plasma treatments intended to improve assay signal clarity through consistent biomolecule immobilization; coatings for medical devices aimed at adhesion and biocompatibility; and precision deposition of drug-eluting coatings for endovascular implants for localized drug delivery. It also offers modular coating systems designed to integrate material functionalization into existing medical and pharmaceutical manufacturing processes.
Business model
TheraDep sells coating services and modular coating systems to medical device and pharmaceutical manufacturers, positioning its deposition equipment to be integrated into customers' existing manufacturing lines rather than requiring separate processing.
▸Full profile — market position, technology, go-to-market
Market position
The company states its process avoids polymer binders, chemical linkers, and heat, operating as a single dry step at room temperature, which allows coating of heat-sensitive materials and yields a coating composed solely of the active biologic or therapeutic material. It also emphasizes substrate versatility across metals, polymers, and ceramics, and modular systems that fit into existing production lines.
Technology
BioDep, a Cold Atmospheric Plasma (bio-atomic deposition) process that uses low-temperature plasma to energize proteins, peptides, and pharmaceuticals so they covalently bond to a substrate in a single dry step at room temperature. The process works on metals, polymers, and ceramics and does not require polymer binders or chemical linkers, leaving a coating of only the active material. The company also supplies modular precision deposition systems, including for drug-eluting coatings.
Go-to-market
Medical device and pharmaceutical manufacturers, including makers of microplates and assay consumables and of endovascular implants.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
In the news
▸Research sources · 1
primary sources listed
- Theradeptheradep.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Theradep do?
- TheraDep applies bioactive and pharmaceutical coatings to devices and labware using a room-temperature cold atmospheric plasma process.
- Who founded Theradep?
- Theradep was founded by Liam O Neill, Liam O'Neill, Pat Burt, John O'Donoghue, Liam in 2015.
- Who are Theradep's investors?
- Theradep's investors include Evolution VC Partners.
- Where is Theradep headquartered?
- Theradep is headquartered in Clonmel, IE.